🚧 Under construction — Data may be inaccurate. We are actively adding more companies and metrics.

Regeneron Pharmaceuticals, Inc. vs Synopsys, Inc.

Market cap comparison over time

Regeneron Pharmaceuticals, Inc.

$79.7B

Rank #191

Synopsys, Inc.

$81.6B

Rank #187

Market Cap Over Time

Key Moments

  • Regeneron Pharmaceuticals, Inc. overtook Synopsys, Inc. by 2011
  • Synopsys, Inc. overtook Regeneron Pharmaceuticals, Inc. by 2020
  • Regeneron Pharmaceuticals, Inc. overtook Synopsys, Inc. by 2022
  • Synopsys, Inc. overtook Regeneron Pharmaceuticals, Inc. by 2023

Year-by-Year Comparison

YearRegeneron Pharmaceuticals, Inc.Synopsys, Inc.Leader
2026$79.7B$81.6BSynopsys, Inc.
2025$79.3B$89.9BSynopsys, Inc.
2024$72.8B$92.9BSynopsys, Inc.
2023$89.7B$98.6BSynopsys, Inc.
2022$73.7B$61.1BRegeneron Pharmaceuticals, Inc.
2021$64.5B$70.6BSynopsys, Inc.
2020$49.4B$49.6BSynopsys, Inc.
2019$38.4B$26.7BRegeneron Pharmaceuticals, Inc.
2018$38.2B$16.1BRegeneron Pharmaceuticals, Inc.
2017$38.4B$16.3BRegeneron Pharmaceuticals, Inc.
2016$37.5B$11.3BRegeneron Pharmaceuticals, Inc.
2015$55.5B$8.7BRegeneron Pharmaceuticals, Inc.
2014$41.9B$8.3BRegeneron Pharmaceuticals, Inc.
2013$28.1B$7.8BRegeneron Pharmaceuticals, Inc.
2012$17.5B$6.1BRegeneron Pharmaceuticals, Inc.
2011$5.7B$5.2BRegeneron Pharmaceuticals, Inc.
2010$3.4B$5.2BSynopsys, Inc.
2009$2.5B$4.3BSynopsys, Inc.
2008$1.9B$3.5BSynopsys, Inc.
2007$2.5B$5.0BSynopsys, Inc.
2006$2.1B$5.1BSynopsys, Inc.
2005$1.6B$3.8BSynopsys, Inc.
2004$941.1M$3.7BSynopsys, Inc.
2003$1.5B$6.5BSynopsys, Inc.
2002$1.9B$4.4BSynopsys, Inc.
2001$2.9B$5.7BSynopsys, Inc.
2000$3.6B$4.5BSynopsys, Inc.
1999$1.3B$6.4BSynopsys, Inc.
1998$753.6M$5.2BSynopsys, Inc.
1997$874.9M$3.4BSynopsys, Inc.
1996$1.6B$4.4BSynopsys, Inc.
1995$1.3B$3.6BSynopsys, Inc.
1994$306.5M$2.1BSynopsys, Inc.